Table 1.
Main clinical features of 58 patients.
| Feature | Findings | |
|---|---|---|
| Sex M/F | 30/28 | |
| Age, median (range), years | 65 (28–89) | |
| Extranodal involvement, % | 17 | |
| Stage, Ann Arbor | Stage I 10 | Stage III 22 |
| Stage II 15 | Stage IV 11 | |
| Bone marrow infiltration, % | 25 | |
| R-IPI risk, % | 1 (Low) 35 | 3 (High intermediate) 21 |
| 2 (Low intermediate) 28 | 4 (High) 16 | |
| PFS, median (range), months | 56 (0–114) | |
| OS, median (range), months | 44 (0–119) | |
M: male; F: female; R-IPI: revised International Prognostic Index; PFS: Progression free survival; OS: Overall survival.